Disulfide With Monoclonal Med18897 .kappa.-chain
Disulfide With Monoclonal Med18897 .kappa.-chain Uses, Dosage, Side Effects, Food Interaction and all others data.
Disulfide With Monoclonal Med18897 .kappa.-chain is under investigation in clinical trial NCT03959488 (A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(rsv) Lower Respiratory Track Infection (LRTI) in High-risk Children).
| Trade Name | Disulfide With Monoclonal Med18897 .kappa.-chain |
| Generic | Nirsevimab |
| Nirsevimab Other Names | Immunoglobulin g1-kappa, anti-(human respiratory syncytial virus fusion glycoprotein f0 (protein f))human monoclonal antibody.gamma.1 heavy chain (1-456) (human vh (homo sapiens ighv1-69*01(ighd)-ighj4*01 (90.1%)) (8.8.19) (1-126) -homo sapiens ighg1*03, Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897 .gamma.1-chain), disulfide with monoclonal med18897 .kappa.-chain, dimer, Nirsevimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Disulfide With Monoclonal Med18897 .kappa.-chain
